Roche @Roche · 24 Jul 2026
#MEDIA – We are pleased to share that the CHMP has recommended approval of our continuous delivery treatment for adults with neovascular age-related macular degeneration (#nAMD) - the leading cause of blindness in people over 60. 👉 https://t.co/XQSDUcT8Ji https://t.co/zEQReo8Lva
3 113Views
16Likes
1Reposts
5Replies
0Quotes
0Bookmarks
Is that a lot?
8.20×vs this author's median380 views is typical
67Percentile for this authorof 12 recent posts
0.52×vs 100K–1M median5 930 views is typical
1.31%Reachviews ÷ followers
0.71%Engagement rateof viewers reacted